Gene-drug interactions (data source: DGIdb)
Gene Name Entrez ID Drug Name Chembl ID Interaction Types Sources publications
PDGFRB 5159 DOVITINIB CHEMBL522892 inhibitor TdgClinicalTrial, ClearityFoundationClinicalTrial, GuideToPharmacologyInteractions, ChemblInteractions
PDGFRB 5159 REGORAFENIB CHEMBL1946170 inhibitor TALC, MyCancerGenome, ChemblInteractions, DrugBank, MyCancerGenomeClinicalTrial
PDGFRB 5159 Famitinib CHEMBL3545026 inhibitor GuideToPharmacologyInteractions, ChemblInteractions
PDGFRB 5159 CHEMBL1908396 CHEMBL1908396 inhibitor GuideToPharmacologyInteractions
PDGFRB 5159 MASITINIB CHEMBL1908391 inhibitor TdgClinicalTrial, GuideToPharmacologyInteractions, ChemblInteractions, MyCancerGenomeClinicalTrial
PDGFRB 5159 MK-2461 CHEMBL1822792 inhibitor GuideToPharmacologyInteractions
PDGFRB 5159 ORANTINIB CHEMBL274654 inhibitor MyCancerGenome, GuideToPharmacologyInteractions, ChemblInteractions
PDGFRB 5159 QUIZARTINIB CHEMBL576982 inhibitor GuideToPharmacologyInteractions, ChemblInteractions
PDGFRB 5159 SEMAXANIB CHEMBL276711 inhibitor GuideToPharmacologyInteractions
PDGFRB 5159 SU-11652 CHEMBL13485 inhibitor GuideToPharmacologyInteractions
PDGFRB 5159 VATALANIB CHEMBL101253 inhibitor TALC, TdgClinicalTrial, GuideToPharmacologyInteractions, ChemblInteractions
PDGFRB 5159 MOTESANIB CHEMBL572881 inhibitor TALC, MyCancerGenome, TdgClinicalTrial, ChemblInteractions
PDGFRB 5159 SORAFENIB TOSYLATE CHEMBL1200485 inhibitor ChemblInteractions, MyCancerGenomeClinicalTrial
PDGFRB 5159 TAK-593 CHEMBL2180604 inhibitor ChemblInteractions
PDGFRB 5159 RG-1530 CHEMBL1980391 inhibitor ChemblInteractions
PDGFRB 5159 MIDOSTAURIN CHEMBL608533 inhibitor ChemblInteractions
PDGFRB 5159 CDP-860 CHEMBL2109544 inhibitor ChemblInteractions
PDGFRB 5159 CEP-2563 CHEMBL3545332 inhibitor ChemblInteractions
PDGFRB 5159 SU-014813 CHEMBL1721885 inhibitor ChemblInteractions
PDGFRB 5159 JI-101 CHEMBL3545155 inhibitor ChemblInteractions
PDGFRB 5159 IMATINIB MESYLATE CHEMBL1642 inhibitor ChemblInteractions
PDGFRB 5159 SORAFENIB CHEMBL1336 antagonist, inhibitor TALC, MyCancerGenome, TdgClinicalTrial, ClearityFoundationClinicalTrial, TEND, DrugBank, MyCancerGenomeClinicalTrial 17545544, 16425993, 17619763
PDGFRB 5159 XL-820 CHEMBL3545402 inhibitor TALC, MyCancerGenome, TdgClinicalTrial, ChemblInteractions, DrugBank
PDGFRB 5159 CEDIRANIB CHEMBL491473 inhibitor TALC, GuideToPharmacologyInteractions, ChemblInteractions
PDGFRB 5159 CRENOLANIB CHEMBL2105728 inhibitor GuideToPharmacologyInteractions, ChemblInteractions
PDGFRB 5159 CHEMBL377193 CHEMBL377193 inhibitor GuideToPharmacologyInteractions
PDGFRB 5159 CHEMBL406375 CHEMBL406375 inhibitor GuideToPharmacologyInteractions
PDGFRB 5159 LUCITANIB CHEMBL2220486 inhibitor GuideToPharmacologyInteractions
PDGFRB 5159 SU-14813 CHEMBL3545160 inhibitor GuideToPharmacologyInteractions, ChemblInteractions
PDGFRB 5159 TANDUTINIB CHEMBL124660 inhibitor MyCancerGenome, GuideToPharmacologyInteractions, ChemblInteractions
PDGFRB 5159 AXITINIB CHEMBL1289926 inhibitor TALC, MyCancerGenome, TdgClinicalTrial
PDGFRB 5159 Puquitinib CHEMBL3545088 inhibitor ChemblInteractions
PDGFRB 5159 PAZOPANIB HYDROCHLORIDE CHEMBL1201733 inhibitor ChemblInteractions
PDGFRB 5159 ILORASERTIB CHEMBL1980297 inhibitor ChemblInteractions
PDGFRB 5159 PD-0166285 (CHEMBL3545196) CHEMBL3545196 inhibitor ChemblInteractions
PDGFRB 5159 DASATINIB CHEMBL1421 antagonist, inhibitor TdgClinicalTrial, ChemblInteractions, TEND, DrugBank, MyCancerGenomeClinicalTrial 20072833, 16497876, 16436588
PDGFRB 5159 XL-999 CHEMBL3545285 inhibitor TdgClinicalTrial, ChemblInteractions, DrugBank
PDGFRB 5159 IMATINIB CHEMBL941 inhibitor MyCancerGenome, TdgClinicalTrial, OncoKB, CGI, CIViC, TEND, FDA 16960151, 12676775, 12181402, 24963404, 14504092, 18950453, 24687085, 22897847, 1516603, 20439456, 21128251, 15503291, 15746584, 15681532, 19620561, 23835704
PDGFRB 5159 NINTEDANIB CHEMBL502835 inhibitor TALC, MyCancerGenome, TdgClinicalTrial, ClearityFoundationClinicalTrial, GuideToPharmacologyInteractions
PDGFRB 5159 NILOTINIB CHEMBL255863 inhibitor MyCancerGenomeClinicalTrial
PDGFRB 5159 AMUVATINIB CHEMBL2103851 TdgClinicalTrial
PDGFRB 5159 NINTEDANIB ESYLATE CHEMBL3039504 inhibitor ChemblInteractions
PDGFRB 5159 CM-082 CHEMBL3545427 inhibitor ChemblInteractions
PDGFRB 5159 TG100-801 CHEMBL403989 inhibitor ChemblInteractions
PDGFRB 5159 SUNITINIB CHEMBL535 inhibitor TALC, MyCancerGenome, TdgClinicalTrial, GuideToPharmacologyInteractions, TEND, DrugBank 12538485, 12748309, 14753710, 15557593, 16425993
PDGFRB 5159 PAZOPANIB CHEMBL477772 inhibitor TALC, MyCancerGenome, GuideToPharmacologyInteractions, DrugBank, MyCancerGenomeClinicalTrial 17288876
PDGFRB 5159 PHENOBARBITAL CHEMBL40 inhibitor GuideToPharmacologyInteractions
PDGFRB 5159 LINIFANIB CHEMBL223360 inhibitor MyCancerGenome, TdgClinicalTrial, GuideToPharmacologyInteractions, ChemblInteractions
PDGFRB 5159 CHEMBL120077 CHEMBL120077 inhibitor GuideToPharmacologyInteractions
PDGFRB 5159 TELATINIB CHEMBL2079588 inhibitor TALC, MyCancerGenome, TdgClinicalTrial, ChemblInteractions
PDGFRB 5159 PEGPLERANIB SODIUM CHEMBL3301576 TdgClinicalTrial
PDGFRB 5159 X-82 CHEMBL3545401 inhibitor MyCancerGenome, ChemblInteractions
PDGFRB 5159 LENVATINIB CHEMBL1289601 TdgClinicalTrial
PDGFRB 5159 SUNITINIB MALATE CHEMBL1567 inhibitor ChemblInteractions
PDGFRB 5159 ENMD-981693 CHEMBL52885 inhibitor ChemblInteractions
PDGFRB 5159 FORETINIB CHEMBL1230609 inhibitor ChemblInteractions
PDGFRB 5159 Anlotinib CHEMBL3545021 inhibitor ChemblInteractions
PDGFRB 5159 BECAPLERMIN CHEMBL1201556 agonist TdgClinicalTrial, ChemblInteractions, TEND, DrugBank 18686746

Variant-drug associations (data source: PharmGKB)
Gene Name Variant Alleles Chemical Phenotype Category Significance Notes Sentence Publications Annotation ID
PDGFRB rs797044887 GT imatinib efficacy no Case study of a pediatric patient who was heterozygous for the N666H mutation in PDGFRB and responded to imatinib treatment. Please note that alleles have been complemented to the positive strand. Genotype GT is associated with response to imatinib in children. 28726812 1449563982